Case Study: Travere Therapeutics keeps drug development on track with Egnyte

How Travere Therapeutics Keeps Drug Development on Track with a Unified Compliance and Collaboration Platform

Travere Therapeutics, a San Diego–based biopharmaceutical company focused on therapies for rare diseases, needed to maintain fast, secure collaboration after consolidating offices and shifting to a largely remote workforce. Legacy cloud access over VPN was slow and unreliable, risking delays to critical drug-development work and complicating regulatory compliance.

After a company‑wide trial, Travere migrated corporate files to Egnyte, linking intranet content for single‑point management and intuitive user access. The change delivered faster, consistent access across devices, reduced storage and backup costs, and strengthened data tracking, governance and compliance (FDA, GDPR, SOX), enabling secure global collaboration without heavy IT overhead.

Travere Therapeutics

Robert Kuhn

Director, IT Infrastructure and Security